Open Access
| Issue |
BIO Web Conf.
Volume 194, 2025
International Scientific Conference on Biotechnology and Food Technology (BFT-2025)
|
|
|---|---|---|
| Article Number | 01091 | |
| Number of page(s) | 15 | |
| DOI | https://doi.org/10.1051/bioconf/202519401091 | |
| Published online | 14 November 2025 | |
- L.E.L. Hendriks, J. Remon, C. Faivre-Finn, et.al., Non-small-cell lung cancer. Nat Rev Dis Primers. 10, 71 (2024). https://doi.org/10.1038/s41572-024-00551-9 [CrossRef] [Google Scholar]
- G.S. Jones, D.R. Baldwin, Recent advances in the management of lung cancer. Clin Med (Lond). 18, s41–s46 (2018). https://doi.org/10.7861/clinmedicine.18-2-s41 [Google Scholar]
- Y. Alduais, H. Zhang, F. Fan, J. Chen, B. Chen, Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment. Medicine (Baltimore). 102, e32899 (2023). https://doi.org/10.1097/MD.0000000000032899 [Google Scholar]
- H.D. Riley, History of the cytomegalovirus. South Med J. 90, 184–190 (1997). https://doi.org/10.1097/00007611-199702000-00004 [Google Scholar]
- D.B. Tan, F.S. Amran, T.H. Teo, P. Price, Y.P. Moodley, Levels of CMV-reactive antibodies correlate with the induction of CD28(null) T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD). Cell Mol Immunol. 13, 551–553 (2016). https://doi.org/10.1038/cmi.2015.4 [Google Scholar]
- C.-P. Kuo, C.-L. Wu, H.-T. Ho, et.al., Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy. Clin Microbiol Infect. 14, 221–227 (2008). https://doi.org/10.1111/j.1469-0691.2007.01895.x [Google Scholar]
- Z. Li, Y. Tang, N. Tang, et.al., High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population. PLoS ONE. 12, e0181440 (2017). https://doi.org/10.1371/journal.pone.0181440 [Google Scholar]
- V. Khurana, H.R. Bejjanki, G. Caldito, M.W. Owens, Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. Chest. 131, 1282–1288 (2007). https://doi.org/10.1378/chest.06-0931 [Google Scholar]
- J.M. Geris, L.G. Spector, R.M. Pfeiffer, et.al., Cancer risk associated with cytomegalovirus infection among solid organ transplant recipients in the United States. Cancer. 128, 3985–3994 (2022). https://doi.org/10.1002/cncr.34462 [Google Scholar]
- I. Barukčić, The causal relationship k. MATEC Web Conf. 336, 09032 (2021). https://doi.org/10.1051/matecconf/202133609032 [CrossRef] [EDP Sciences] [Google Scholar]
- S. Rashid, A. Ardeljan, L.R. Frankel, et.al., Human Cytomegalovirus (CMV) Infection Associated With Decreased Risk of Bronchogenic Carcinoma: Understanding How a Previous CMV Infection Leads to an Enhanced Immune Response Against Malignancy. Cureus. 15, e37265 (2023). https://doi.org/10.7759/cureus.37265 [Google Scholar]
- L.R. Smith, M.K. Wloch, J.A. Chaplin, M. Gerber, A.P. Rolland, Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial. Vaccines (Basel). 1, 398–414 (2013). https://doi.org/10.3390/vaccines1040398 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.